SCHEDULE: Castle Creek Reduces CF Bankshares Stake to 6.1%
Beneficial Ownership Amendment
Castle Creek Capital Partners VII, LP has reduced its beneficial ownership in CF Bankshares Inc. to 6.1% after selling 67,918 shares for over $1.6 million.
Summary
- Castle Creek Capital Partners VII, LP (Fund VII) filed Amendment No. 19 to its Schedule 13D for CF Bankshares Inc.
- Between November 26, 2025, and December 8, 2025, Fund VII sold an aggregate of 67,918 shares of CF Bankshares' Voting Common Stock.
- The total proceeds from these sales, net of commissions and fees, amounted to $1,614,766.93.
- Following these transactions, Fund VII now beneficially owns 388,065 shares of Voting Common Stock.
- This ownership represents approximately 6.1% of the total 6,367,075 shares outstanding as of November 4, 2025.
- Detailed open-market sales transactions were reported, with weighted average prices ranging from $23.75 to $24.06 per share.
Sentiment
Score: 3
Explanation: The sentiment is moderately negative due to a significant institutional investor reducing its stake, which can signal a lack of conviction or a strategic exit, potentially impacting investor confidence and stock price.
Positives
- The transactions occurred in open-market, broker-assisted sales, indicating liquidity for the shares.
Negatives
- A significant institutional investor, Castle Creek Capital Partners VII, LP, has reduced its stake in CF Bankshares Inc.
- The reduction of 67,918 shares suggests a decrease in conviction or a strategic portfolio rebalancing by the investor.
- The sale of shares could put downward pressure on the stock price, especially if other investors interpret it as a negative signal.
Risks
- Reduced institutional ownership could lead to decreased investor confidence.
- Potential for further sales by Castle Creek Capital Partners VII, LP, which could exert additional selling pressure on the stock.
- The market might interpret the sale as a signal of concerns regarding the company's future performance or valuation.
Future Outlook
This Schedule 13D amendment does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
The reduction in stake by a private equity firm like Castle Creek Capital, which specializes in financial services, could reflect a strategic portfolio adjustment or a response to specific market conditions within the banking sector. While not explicitly stated, such sales can sometimes occur when an investor believes a company's valuation has reached a favorable point for exit or when capital is reallocated to other opportunities within the financial industry.
Comparison to Industry Standards
- NA
Stakeholder Impact
- **Shareholders**: Existing shareholders may experience downward pressure on the stock price due to the increased supply of shares from the institutional sale and potential negative market sentiment. Future shareholders might view the reduced institutional stake as a less attractive investment.
- **Company Management**: Management may face questions regarding the reasons for the institutional investor's reduced stake and its implications for the company's valuation and strategic direction.
Next Steps
- This filing does not explicitly mention any future actions, events, or milestones for CF Bankshares Inc. or Castle Creek Capital beyond the reported transactions.
Key Dates
| Date | Description |
|---|---|
| 2019-12-24 | Original Schedule 13D filed. |
| 2020-03-31 | Amendment No. 1 to Schedule 13D filed. |
| 2020-06-01 | Amendment No. 2 to Schedule 13D filed. |
| 2024-11-26 | Amendment No. 3 to Schedule 13D filed. |
| 2024-12-03 | Amendment No. 4 to Schedule 13D filed. |
| 2024-12-12 | Amendment No. 5 to Schedule 13D filed. |
| 2025-05-14 | Amendment No. 6 to Schedule 13D filed. |
| 2025-05-22 | Amendment No. 7 to Schedule 13D filed. |
| 2025-07-03 | Amendment No. 8 to Schedule 13D filed. |
| 2025-07-10 | Amendment No. 9 to Schedule 13D filed. |
| 2025-07-23 | Amendment No. 10 to Schedule 13D filed. |
| 2025-08-15 | Amendment No. 11 to Schedule 13D filed. |
| 2025-08-26 | Amendment No. 12 to Schedule 13D filed. |
| 2025-08-29 | Amendment No. 13 to Schedule 13D filed. |
| 2025-09-08 | Amendment No. 14 to Schedule 13D filed. |
| 2025-09-10 | Amendment No. 15 to Schedule 13D filed. |
| 2025-09-23 | Amendment No. 16 to Schedule 13D filed. |
| 2025-10-08 | Amendment No. 17 to Schedule 13D filed. |
| 2025-11-04 | Date of shares outstanding calculation (6,367,075 shares) reported in Company's 10-Q. |
| 2025-11-07 | Company's Quarterly Report on Form 10-Q filed with the SEC. |
| 2025-11-26 | First reported sale of 1,237 shares at a weighted average price of $24.06 per share. |
| 2025-11-28 | Amendment No. 18 to Schedule 13D filed; Sale of 112 shares at $24.00 per share. |
| 2025-12-01 | Sale of 18,824 shares at a weighted average price of $23.81 per share. |
| 2025-12-02 | Sale of 5,266 shares at a weighted average price of $23.75 per share. |
| 2025-12-03 | Sale of 20,825 shares at a weighted average price of $23.79 per share. |
| 2025-12-04 | Sale of 11,494 shares at a weighted average price of $23.85 per share. |
| 2025-12-05 | Sale of 3,135 shares at a weighted average price of $23.76 per share. |
| 2025-12-08 | Date of event requiring filing; Sale of 7,025 shares at a weighted average price of $23.79 per share. |
| 2025-12-10 | Signature date of Tony Scavuzzo for Castle Creek Capital Partners VII, LP and Castle Creek Capital VII LLC. |
Recommendation
holdWhile a significant institutional investor has reduced its stake, the filing itself does not provide fundamental reasons for the sale beyond the transaction details. The reduction in ownership by Castle Creek Capital could be a portfolio rebalancing rather than a direct negative assessment of CF Bankshares' fundamentals. Investors should hold and monitor future filings and company performance for more comprehensive insights before making a 'buy' or 'sell' decision. The current information suggests a cautious stance.
Keywords
CF Bankshares, Castle Creek Capital, Schedule 13D, Beneficial Ownership, Stock Sale, Institutional Investor, Financial Services, Banking, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.